Sanofi Competitors and Similar CompaniesClear all
Viatris's competitors and similar companies include AstraZeneca, Lilly and Pfizer.
 Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | |
Founding Date | Founding Date 2020 | Founding Date 1999 | Founding Date 1876 | Founding Date 1849 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more |
Employees | Employees 38,0003% increase | Employees 94,300 | Employees 47,0009% increase | Employees 81,0008% decrease |
Valuation ($) | Valuation ($) 14 b | Valuation ($) 2.7 b | Valuation ($) 903.4 b | Valuation ($) 163.9 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) $65.2b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) |
Cost of goods | Cost of goods $9.3b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods $11.1b (FY, 2025) | Cost of goods $16.1b (FY, 2025) |
Gross profit | Gross profit $5b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit $54.1b (FY, 2025) | Gross profit $46.5b (FY, 2025) |
Net income | Net income ($3.5b) (FY, 2025) | Net income $10.2b (FY, 2025) | Net income $20.6b (FY, 2025) | Net income $7.8b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries 165 (Q1, 2023) | Countries 130 (FY, 2021) | Countries 120 (FY, 2021) | Countries 200 (FY, 2024) |
Manufacturing Sites | Manufacturing Sites 40 (Q1, 2023) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 37 (FY, 2024) |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 27 (FY, 2019) | Phase I Trials Products 51 (FY, 2024) |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 8 (FY, 2021) | Phase II Trials Products 27 (FY, 2024) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 10 (FY, 2021) | Phase III Trials Products 32 (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
AstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyLilly
HQ
Indianapolis, US
Employees
47,000↑ 9% increase
Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company